Pfizer Ireland Plant Receives ISPE Award

October 16, 2014
Randi Hernandez

Randi Hernandez was science editor at BioPharm International from September 2014 to May 2017.

Pfizer's addition of a new vaccine suite and multiproduct bioprocess suite to its Ireland facility win the company the title of 2014 Facility of the Year.

The International Society for Pharmaceutical Engineers (ISPE) recognized Pfizer Ireland as the overall winner in the 2014 Facility of the Year Awards (FOYA) category at the society’s annual meeting in Las Vegas, Nevada. FOYA acknowledges the pharmaceutical manufacturing industry’s accomplishments in construction and facility design and the pursuit of new technologies.

The focus of Pfizer Ireland’s Network Strategy Implementation (NSI) Capacity project was the addition of a new vaccine suite and a drug substance bioprocess suite. The new manufacturing suites included the latest technologies, including electronic batch records, process analytical technology, and disposable bag processing. Pfizer Ireland conducted the project using a lean management strategy, a 5S program in the design process, and a Six Sigma toolkit. The Pfizer Ireland Grange Castle plant that won the award is located in Clondalkin, South County Dublin.

“The society was impressed with the NSI Capacity Expansion project and the company’s ability to effectively manage the challenges of maintaining supply with the demolition of existing facilities, new construction, and start-up and integration activities,” said Chair of the FOYA Judging Panel James Breen in a press release.

SOURCE: ISPE

Related Content:

News | Quality/GMPs | Biopharma News